determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?

Publikation: Bidrag til tidsskriftReviewForskning

OriginalsprogEngelsk
TidsskriftHormone Research
Vol/bind51
Sider (fra-til)141-148
Antal sider7
ISSN0301-0163
StatusUdgivet - 1999

ID: 48484236